{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:57:56Z","timestamp":1794650276023,"version":"4.9.1"},"reference-count":69,"publisher":"American Chemical Society (ACS)","issue":"11","license":[{"start":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T00:00:00Z","timestamp":1470614400000},"content-version":"vor","delay-in-days":133,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccby_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["T32 GM008666"],"award-info":[{"award-number":["T32 GM008666"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["R01 AI090141"],"award-info":[{"award-number":["R01 AI090141"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["R01 AI093716"],"award-info":[{"award-number":["R01 AI093716"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["R01 AI099105"],"award-info":[{"award-number":["R01 AI099105"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["R01 AI103058"],"award-info":[{"award-number":["R01 AI103058"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["U19 AI089696"],"award-info":[{"award-number":["U19 AI089696"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1040406"],"award-info":[{"award-number":["OPP1040406"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1053604"],"award-info":[{"award-number":["OPP1053604"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1054480"],"award-info":[{"award-number":["OPP1054480"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1067805"],"award-info":[{"award-number":["OPP1067805"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>MMV007564 is a novel antimalarial benzimidazolyl piperidine chemotype identified in cellular screens. To identify the genetic determinant of MMV007564 resistance, parasites were cultured in the presence of the compound to generate resistant lines. Whole genome sequencing revealed distinct mutations in the gene named Plasmodium falciparum cyclic amine resistance locus (pfcarl), encoding a conserved protein of unknown function. Mutations in pfcarl are strongly associated with resistance to a structurally unrelated class of compounds, the imidazolopiperazines, including KAF156, currently in clinical trials. Our data demonstrate that pfcarl mutations confer resistance to two distinct compound classes, benzimidazolyl piperidines and imidazolopiperazines. However, MMV007564 and the imidazolopiperazines, KAF156 and GNF179, have different timings of action in the asexual blood stage and different potencies against the liver and sexual blood stages. These data suggest that pfcarl is a multidrug-resistance gene rather than a common target for benzimidazolyl piperidines and imidazolopiperazines.<\/jats:p>","DOI":"10.1021\/acsinfecdis.6b00025","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T21:11:25Z","timestamp":1459199485000},"page":"816-826","source":"Crossref","is-referenced-by-count":50,"title":["<i>Plasmodium falciparum<\/i>\n                    Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for\nTwo Distinct Compound Classes"],"prefix":"10.1021","volume":"2","author":[{"given":"Pamela A.","family":"Magistrado","sequence":"first","affiliation":[{"name":"Harvard T. H. Chan School of Public Health , , , ,","place":["Boston, Massachusetts, United States, 02115"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria C.","family":"Corey","sequence":"additional","affiliation":[{"name":"University of California\u2500San Diego , , , ,","place":["La Jolla, California, United States, 92093"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda K.","family":"Lukens","sequence":"additional","affiliation":[{"name":"Harvard T. H. Chan School of Public Health , , , ,","place":["Boston, Massachusetts, United States, 02115"]},{"name":"The Broad Institute , , 415 Main Street , , ,","place":["Cambridge, Massachusetts, United States, 02142"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"LaMonte","sequence":"additional","affiliation":[{"name":"University of California\u2500San Diego , , , ,","place":["La Jolla, California, United States, 92093"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Sasaki","sequence":"additional","affiliation":[{"name":"University of California\u2500San Diego , , , ,","place":["La Jolla, California, United States, 92093"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Meister","sequence":"additional","affiliation":[{"name":"University of California\u2500San Diego , , , ,","place":["La Jolla, California, United States, 92093"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Wree","sequence":"additional","affiliation":[{"name":"University of California\u2500San Diego , , , ,","place":["La Jolla, California, United States, 92093"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Winzeler","sequence":"additional","affiliation":[{"name":"University of California\u2500San Diego , , , ,","place":["La Jolla, California, United States, 92093"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dyann F.","family":"Wirth","sequence":"additional","affiliation":[{"name":"Harvard T. H. Chan School of Public Health , , , ,","place":["Boston, Massachusetts, United States, 02115"]},{"name":"The Broad Institute , , 415 Main Street , , ,","place":["Cambridge, Massachusetts, United States, 02142"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2016,3,28]]},"reference":[{"key":"2026090216315800000_cit1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.pt.2015.11.015","article-title":"Malaria parasites\nin the asymptomatic:\nlooking for the hay in the haystack","volume":"32","author":"Galatas","year":"2016","journal-title":"Trends\nParasitol."},{"key":"2026090216315800000_cit2","unstructured":"World Health Organization.\n          \n          2015)  World\nMalaria Report, Geneva, Switzerland."},{"key":"2026090216315800000_cit3","unstructured":"Malaria Elimination\nInitiative.\n(2015) Country Briefing, MEI, UCSF."},{"issue":"4","key":"2026090216315800000_cit4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","article-title":"Spread\nof artemisinin-resistant Plasmodium falciparum in\nMyanmar: a cross-sectional survey of the K13 molecular marker","volume":"15","author":"Tun","year":"2015","journal-title":"Lancet Infect. Dis."},{"issue":"24","key":"2026090216315800000_cit5","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Evidence of artemisinin-resistant\nmalaria in western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"2026090216315800000_cit6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"7481","key":"2026090216315800000_cit7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of\nartemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"issue":"9830","key":"2026090216315800000_cit8","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","article-title":"Emergence of artemisinin-resistant malaria on the western border\nof Thailand: a longitudinal study","volume":"379","author":"Phyo","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"2026090216315800000_cit9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.7883\/yoken.65.465","article-title":"Evolution\nof Plasmodium falciparum drug resistance: implications\nfor the development and containment\nof artemisinin resistance","volume":"65","author":"Mita","year":"2012","journal-title":"Jpn. J. Infect. Dis."},{"issue":"11","key":"2026090216315800000_cit10","doi-asserted-by":"publisher","first-page":"e26005","DOI":"10.1371\/journal.pone.0026005","article-title":"Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan\ncoast","volume":"6","author":"Borrmann","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"2026090216315800000_cit11","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1590\/0074-0276130167","article-title":"Evidence of an increased\nincidence of day 3 parasitaemia in Suriname:\nan indicator of the emerging resistance of Plasmodium falciparum to artemether","volume":"108","author":"Vreden","year":"2013","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"12","key":"2026090216315800000_cit12","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrmicro3138","article-title":"Antimalarial drug discovery \u2013\napproaches and progress towards new medicines","volume":"11","author":"Flannery","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"issue":"11","key":"2026090216315800000_cit15","doi-asserted-by":"publisher","first-page":"6437","DOI":"10.1128\/AAC.03478-14","article-title":"A first-in-human randomized,\ndouble-blind, placebo-controlled, single-\nand multiple-ascending oral dose study of novel imidazolopiperazine\nKAF156 to assess its safety, tolerability, and pharmacokinetics in\nhealthy adult volunteers","volume":"58","author":"Leong","year":"2014","journal-title":"Antimicrob. Agents\nChemother."},{"issue":"9","key":"2026090216315800000_cit16","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1128\/AAC.02727-13","article-title":"KAF156 is an antimalarial clinical candidate with potential for use\nin prophylaxis, treatment, and prevention of disease transmission","volume":"58","author":"Kuhen","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026090216315800000_cit17","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1126\/science.1211936","article-title":"Imaging of Plasmodium liver stages to drive next-generation antimalarial\ndrug discovery","volume":"334","author":"Meister","year":"2011","journal-title":"Science"},{"issue":"5429","key":"2026090216315800000_cit18","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1126\/science.285.5429.901","article-title":"Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis","volume":"285","author":"Winzeler","year":"1999","journal-title":"Science"},{"issue":"5922","key":"2026090216315800000_cit19","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1126\/science.1167983","article-title":"Comprehensive characterization of genes required\nfor protein folding\nin the endoplasmic reticulum","volume":"323","author":"Jonikas","year":"2009","journal-title":"Science"},{"issue":"2","key":"2026090216315800000_cit20","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1534\/genetics.106.065177","article-title":"Mutation of a ubiquitously expressed mouse transmembrane protein\n(Tapt1) causes specific skeletal homeotic transformations","volume":"175","author":"Howell","year":"2007","journal-title":"Genetics"},{"issue":"26","key":"2026090216315800000_cit21","doi-asserted-by":"publisher","first-page":"9059","DOI":"10.1073\/pnas.0802982105","article-title":"In silico activity profiling reveals the mechanism\nof action of antimalarials\ndiscovered in a high-throughput screen","volume":"105","author":"Plouffe","year":"2008","journal-title":"Proc.\nNatl. Acad. Sci. U.S.A."},{"issue":"6","key":"2026090216315800000_cit22","doi-asserted-by":"publisher","first-page":"e62906","DOI":"10.1371\/journal.pone.0062906","article-title":"The open access malaria\nbox: a drug discovery catalyst for neglected\ndiseases","volume":"8","author":"Spangenberg","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"2026090216315800000_cit23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1128\/AAC.01500-13","article-title":"Antiapicoplast and gametocytocidal\nscreening to identify the mechanisms\nof action of compounds within the malaria box","volume":"58","author":"Bowman","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026090216315800000_cit24","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/1475-2875-12-408","article-title":"Identification of\ninhibitors of Plasmodium falciparum gametocyte development","volume":"12","author":"Duffy","year":"2013","journal-title":"Malar. J."},{"issue":"6061","key":"2026090216315800000_cit25","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1126\/science.1211936","article-title":"Imaging of Plasmodium liver stages to drive next-generation\nantimalarial drug discovery","volume":"334","author":"Meister","year":"2011","journal-title":"Science"},{"issue":"1","key":"2026090216315800000_cit26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.chom.2015.12.001","article-title":"High-throughput assay and discovery of small molecules that interrupt\nmalaria transmission","volume":"19","author":"Plouffe","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"12","key":"2026090216315800000_cit27","doi-asserted-by":"publisher","first-page":"7292","DOI":"10.1128\/AAC.03666-14","article-title":"A male and female gametocyte functional viability assay to identify\nbiologically relevant malaria transmission-blocking drugs","volume":"58","author":"Ruecker","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026090216315800000_cit28","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1038\/srep03743","article-title":"Chemical signatures\nand new drug targets for gametocytocidal drug\ndevelopment","volume":"4","author":"Sun","year":"2014","journal-title":"Sci. Rep."},{"issue":"1","key":"2026090216315800000_cit29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/s12936-015-0962-2","article-title":"Identifying rapidly parasiticidal anti-malarial drugs using a simple\nand reliable in vitro parasite viability fast assay","volume":"14","author":"Linares","year":"2015","journal-title":"Malar. J."},{"issue":"20","key":"2026090216315800000_cit30","doi-asserted-by":"publisher","first-page":"7761","DOI":"10.1021\/jm400325j","article-title":"Using genetic methods\nto define the\ntargets of compounds with antimalarial activity","volume":"56","author":"Flannery","year":"2013","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026090216315800000_cit31","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.1371\/journal.pbio.0000005","article-title":"The transcriptome of\nthe intraerythrocytic developmental cycle of Plasmodium falciparum","volume":"1","author":"Bozdech","year":"2003","journal-title":"PLoS Biol."},{"key":"2026090216315800000_cit32","unstructured":"Gagaring, K. B. R., Francek, C., Chen, Z., Buenviaje, J., Plouffe, D., Winzeler, E., Brinker, A., Diagana, T., Taylor, J., Glynne, R., Chatterjee, A., Kuhen, K. Genomics Institute of the Novartis Research Foundation\n(GNF): 10675 John Jay Hopkins Drive, San Diego CA 92121, USA, and\nNovartis Institute for Tropical Disease, 10 Biopolis Road, Chromos\n05-01, 138 670 Singapore."},{"issue":"5639","key":"2026090216315800000_cit33","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science.1087025","article-title":"Discovery of gene function by expression profiling\nof the malaria parasite life cycle","volume":"301","author":"Le Roch","year":"2003","journal-title":"Science"},{"issue":"4","key":"2026090216315800000_cit34","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/nar\/gkj517","article-title":"Comparative whole genome transcriptome analysis of three Plasmodium falciparum strains","volume":"34","author":"Llina\u0301s","year":"2006","journal-title":"Nucleic\nAcids Res."},{"issue":"9","key":"2026090216315800000_cit35","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1021\/jm300041e","article-title":"Imidazolopiperazines: lead optimization of the second-generation\nantimalarial agents","volume":"55","author":"Nagle","year":"2012","journal-title":"J. Med. Chem."},{"key":"2026090216315800000_cit36","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1021\/jm2003359","volume":"54","author":"Wu","year":"2011","journal-title":"J.\nMed. Chem."},{"issue":"11","key":"2026090216315800000_cit37","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.febslet.2011.04.042","article-title":"Drug-resistant\nmalaria: molecular\nmechanisms and implications for public health","volume":"585","author":"Petersen","year":"2011","journal-title":"FEBS Lett."},{"issue":"52","key":"2026090216315800000_cit38","doi-asserted-by":"publisher","first-page":"36336","DOI":"10.1074\/jbc.M114.614206","article-title":"Multiple drugs compete for transport via the Plasmodium falciparum chloroquine resistance transporter\nat distinct but interdependent\nsites","volume":"289","author":"Bellanca","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"50","key":"2026090216315800000_cit39","doi-asserted-by":"publisher","first-page":"35078","DOI":"10.1074\/jbc.M804990200","article-title":"Identification and characterization\nof small molecule inhibitors\nof Plasmodium falciparum dihydroorotate dehydrogenase","volume":"283","author":"Patel","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"43","key":"2026090216315800000_cit40","doi-asserted-by":"publisher","first-page":"33054","DOI":"10.1074\/jbc.M110.162081","article-title":"Novel inhibitors of Plasmodium falciparum dihydroorotate\ndehydrogenase with anti-malarial activity in the mouse model","volume":"285","author":"Booker","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2026090216315800000_cit41","doi-asserted-by":"publisher","first-page":"17980","DOI":"10.1074\/jbc.M114.558353","article-title":"In vitro resistance\nselections for Plasmodium falciparum dihydroorotate\ndehydrogenase inhibitors give mutants with multiple\npoint mutations in the drug-binding site and altered growth","volume":"289","author":"Ross","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"7","key":"2026090216315800000_cit42","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1021\/jm801343r","article-title":"Identification of a metabolically stable triazolopyrimidine-based\ndihydroorotate dehydrogenase inhibitor with antimalarial activity\nin mice","volume":"52","author":"Gujjar","year":"2009","journal-title":"J. Med. Chem."},{"issue":"12","key":"2026090216315800000_cit43","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1021\/jm8001026","article-title":"Triazolopyrimidine-based\ndihydroorotate dehydrogenase inhibitors\nwith potent and selective activity against the malaria parasite Plasmodium falciparum","volume":"51","author":"Phillips","year":"2008","journal-title":"J. Med. Chem."},{"issue":"2","key":"2026090216315800000_cit44","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1073\/pnas.1320886110","volume":"111","author":"Lukens","year":"2014","journal-title":"Proc. Natl. Acad.\nSci. U.S.A."},{"issue":"3","key":"2026090216315800000_cit45","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijpddr.2015.07.001","article-title":"The malaria parasite cation ATPase PfATP4 and its role in the mechanism\nof action of a new arsenal of antimalarial drugs","volume":"5","author":"Spillman","year":"2015","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"issue":"7","key":"2026090216315800000_cit46","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/0006-2952(92)90213-3","article-title":"Site of action of the\nantimalarial hydroxynaphthoquinone,\n2-[trans-4-(4\u2032-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone\n(566C80)","volume":"43","author":"Fry","year":"1992","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"2026090216315800000_cit47","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1046\/j.1365-2958.1999.01515.x","article-title":"Resistance mutations reveal the atovaquone-binding domain of cytochrome\nb in malaria parasites","volume":"33","author":"Srivastava","year":"1999","journal-title":"Mol. Microbiol."},{"issue":"11","key":"2026090216315800000_cit48","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1021\/cb200105d","article-title":"A chemical genomic analysis of decoquinate, a Plasmodium falciparum cytochrome b inhibitor","volume":"6","author":"Nam","year":"2011","journal-title":"ACS Chem. Biol."},{"issue":"12","key":"2026090216315800000_cit49","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.chembiol.2011.09.016","article-title":"Identification and validation\nof tetracyclic benzothiazepines as Plasmodium falciparum cytochrome bc(1) inhibitors","volume":"18","author":"Dong","year":"2011","journal-title":"Chem. Biol."},{"issue":"18","key":"2026090216315800000_cit50","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.4155\/fmc.12.177","article-title":"Exploration of 4(1H)-pyridones as a novel family of potent antimalarial\ninhibitors of the plasmodial cytochrome bc1","volume":"4","author":"Bueno","year":"2012","journal-title":"Future Med. Chem."},{"issue":"7","key":"2026090216315800000_cit51","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/infdis\/jiu565","article-title":"Diversity-oriented synthesis\nprobe targets Plasmodium falciparum cytochrome b\nubiquinone reduction site and synergizes with oxidation\nsite inhibitors","volume":"211","author":"Lukens","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"177","key":"2026090216315800000_cit52","doi-asserted-by":"publisher","first-page":"177ra37","DOI":"10.1126\/scitranslmed.3005029","article-title":"Quinolone-3-diarylethers: a new class of antimalarial drug","volume":"5","author":"Nilsen","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"7479","key":"2026090216315800000_cit53","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature12782","article-title":"Targeting Plasmodium PI(4)K to eliminate malaria","volume":"504","author":"McNamara","year":"2013","journal-title":"Nature"},{"issue":"Suppl. 1","key":"2026090216315800000_cit54","doi-asserted-by":"publisher","first-page":"P38","DOI":"10.1186\/1475-2875-13-S1-P38","article-title":"Identification of Plasmodium PI4 kinase as target\nof MMV390048 by chemoproteomics","volume":"13","author":"Ghidelli-Disse","year":"2014","journal-title":"Malar. J."},{"issue":"10","key":"2026090216315800000_cit55","doi-asserted-by":"publisher","first-page":"e1003257","DOI":"10.1371\/journal.pcbi.1003257","article-title":"Prediction of the P. falciparum target space relevant to malaria drug\ndiscovery","volume":"9","author":"Spitzmuller","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"2026090216315800000_cit56","doi-asserted-by":"publisher","first-page":"D539","DOI":"10.1093\/nar\/gkn814","article-title":"PlasmoDB:\na functional genomic database for malaria parasites","volume":"37","author":"Aurrecoechea","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"2026090216315800000_cit57","unstructured":"(2015) The Pf3K Project:\npilot data release 4; http:\/\/www.malariagen.net\/data\/pf3k-4."},{"issue":"8","key":"2026090216315800000_cit58","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1128\/AAC.01793-10","article-title":"Piperaquine resistance\nis associated with a copy number variation\non chromosome 5 in drug-pressured Plasmodium falciparum parasites","volume":"55","author":"Eastman","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"2026090216315800000_cit59","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1021\/cb500616x","article-title":"Mutations in the P-type cation-transporter ATPase 4, PfATP4, mediate\nresistance to both aminopyrazole and spiroindolone antimalarials","volume":"10","author":"Flannery","year":"2015","journal-title":"ACS Chem. Biol."},{"issue":"17","key":"2026090216315800000_cit60","doi-asserted-by":"publisher","first-page":"9389","DOI":"10.1073\/pnas.94.17.9389","article-title":"Variations\nin frequencies of drug\nresistance in Plasmodium falciparum","volume":"94","author":"Rathod","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"2026090216315800000_cit61","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/1475-2875-11-292","article-title":"A framework\nfor assessing the risk\nof resistance for anti-malarials in development","volume":"11","author":"Ding","year":"2012","journal-title":"Malar. J."},{"issue":"6","key":"2026090216315800000_cit62","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/jac\/36.6.1073","article-title":"Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria","volume":"36","author":"Chiodini","year":"1995","journal-title":"J.\nAntimicrob. Chemother."},{"issue":"1","key":"2026090216315800000_cit63","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4269\/ajtmh.1996.54.62","article-title":"Clinical studies of\natovaquone, alone or in combination with other\nantimalarial drugs, for treatment of acute uncomplicated malaria in\nThailand","volume":"54","author":"Looareesuwan","year":"1996","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"8","key":"2026090216315800000_cit64","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1128\/AAC.44.8.2100-2108.2000","article-title":"Mutations in Plasmodium falciparum cytochrome b\nthat are associated with atovaquone resistance are located at a putative\ndrug-binding site","volume":"44","author":"Korsinczky","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"2026090216315800000_cit65","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2165\/00003495-200363060-00006","article-title":"Atovaquone\/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria","volume":"63","author":"McKeage","year":"2003","journal-title":"Drugs"},{"issue":"47","key":"2026090216315800000_cit66","doi-asserted-by":"publisher","first-page":"E3278","DOI":"10.1073\/pnas.1209823109","article-title":"Plasmodium falciparum responds to amino acid starvation\nby entering into a hibernatory state","volume":"109","author":"Babbitt","year":"2012","journal-title":"Proc.\nNatl. Acad. Sci. U.S.A."},{"issue":"4254","key":"2026090216315800000_cit67","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"issue":"1","key":"2026090216315800000_cit68","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nm808","article-title":"Hepatocyte CD81 is required\nfor Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity","volume":"9","author":"Silvie","year":"2002","journal-title":"Nat.\nMed."},{"issue":"1","key":"2026090216315800000_cit69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-15-63","article-title":"Identification of pathogen genomic variants through an integrated\npipeline","volume":"15","author":"Manary","year":"2014","journal-title":"BMC Bioinf."},{"issue":"6","key":"2026090216315800000_cit70","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1128\/AAC.01607-06","article-title":"Assessment and continued\nvalidation of the malaria SYBR Green I-based\nfluorescence assay for use in malaria drug screening","volume":"51","author":"Johnson","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"2026090216315800000_cit71","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","article-title":"Novel phenotypic assays\nfor the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and\nex-vivo drug-response studies","volume":"13","author":"Witkowski","year":"2013","journal-title":"Lancet Infect.\nDis."}],"container-title":["ACS Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsinfecdis.6b00025","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article-pdf\/2\/11\/816\/67003721\/acsinfecdis.6b00025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article-pdf\/2\/11\/816\/67003721\/acsinfecdis.6b00025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:32:04Z","timestamp":1788381124000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article\/2\/11\/816\/1484822\/Plasmodium-falciparum-Cyclic-Amine-Resistance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,28]]},"references-count":69,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,3,28]]},"published-print":{"date-parts":[[2016,11,11]]}},"URL":"https:\/\/doi.org\/10.1021\/acsinfecdis.6b00025","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acsinfecdis.6b00025.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acsinfecdis.6b00025.s002","asserted-by":"subject"}]},"ISSN":["2373-8227"],"issn-type":[{"value":"2373-8227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,28]]}}}